43 results on '"Tomaszewski, John E."'
Search Results
2. Chapter 16 - Overview of the role of artificial intelligence in pathology: The computer as a pathology digital assistant
3. Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey
4. Contributors
5. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study
6. Chapter 11 - Overview of the role of artificial intelligence in pathology: the computer as a pathology digital assistant
7. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma
8. Urine Markers Do Not Predict Biopsy Findings or Presence of Bladder Ulcers in Interstitial Cystitis/Painful Bladder Syndrome
9. Discovery of Morphological Subgroups That Correlate With Severity of Symptoms in Interstitial Cystitis: A Proposed Biopsy Classification System
10. Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging
11. Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidney
12. Impact of the percentage of positive biopsy cores on the further stratification of primary grade 3 and grade 4 Gleason score 7 tumors in radical prostatectomy patients
13. Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer
14. IS URINE METHYLHISTAMINE A USEFUL MARKER FOR INTERSTITIAL CYSTITIS?
15. The Role of Calretinin, Inhibin, Melan-A, BCL-2, and C-kit in Differentiating Adrenal Cortical and Medullary Tumors: An Immunohistochemical Study
16. Clinical utility of endorectal MRI in determining PSA outcome for patients with biopsy Gleason score 7, PSA ≤10, and clinically localized prostate cancer
17. Using PSA, biopsy Gleason score, clinical stage, and the percentage of positive biopsies to identify optimal candidates for prostate-only radiation therapy
18. Lower Prostate Specific Antigen Outcome Than Expected Following Radical Prostatectomy in Patients With High Grade Prostate and a Prostatic Specific Antigen Level of 4 Ng/Ml. or Less
19. Metachronous Epstein-Barr virus–related smooth muscle tumors in a child after heart transplantation: Case report and review of the literature
20. Estimating the impact on prostate cancer mortality of incorporating prostate-specific antigen testing into screening
21. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study
22. PREDICTING PROSTATE SPECIFIC ANTIGEN OUTCOME PREOPERATIVELY IN THE PROSTATE SPECIFIC ANTIGEN ERA
23. Endorectal coil magnetic resonance imaging and clinicopathologic findings in T1c adenocarcinoma of the prostate
24. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer
25. ENDORECTAL MAGNETIC RESONANCE IMAGING AS A PREDICTOR OF BIOCHEMICAL OUTCOME AFTER RADICAL PROSTATECTOMY IN MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER
26. Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy gleason score, and clinical T-stage
27. Contributors
28. 1759: The Antecedent History of High Grade Prostatic Intraepithelial Neoplasia in a Radical Prostatectomy Cohort
29. 1414: Estimated Tumor Volume Provides Independent Predictive Information on Biochemical Outcome in High Grade Radical Prostatectomy Patients
30. Section Editors
31. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV
32. Treatment of bladder cancer with interstitial iridium-192 implantation and external beam irradiation
33. Effect of Nonanticoagulant Heparin (Astenose) on Restenosis after Balloon Angioplasty in the Atherosclerotic Rabbit
34. A prostate gland volume of more than 75 cm 3 predicts for a favorable outcome after radical prostatectomy for localized prostate cancer
35. Combined modality staging of prostate carcinoma and its utility in predicting pathologic stage and postoperative prostate specific antigen failure
36. An analysis of the time course of postoperative prostate-specific antigen failure in patients with positive surgical margins: Implications on the use of adjuvant therapy
37. Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease
38. A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate Cancer
39. Strategy for Repeat Biopsy of Patients with Prostatic Intraepithelial Neoplasia Detected by Prostate Needle Biopsy
40. THE COMBINATION OF PREOPERATIVE PROSTATE SPECIFIC ANTIGEN AND POSTOPERATIVE PATHOLOGICAL FINDINGS TO PREDICT PROSTATE SPECIFIC ANTIGEN OUTCOME IN CLINICALLY LOCALIZED PROSTATE CANCER
41. Progressive angiomyolipoma with inferior vena cava tumor thrombus
42. 5 year biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
43. Acute Renal Failure Secondary to Carcinomatous Lymphatic Metastases to Kidneys
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.